The face of hope for treatment for traumatic brain injury just got a bit brighter with the introduction of something called Oxycyte. This is a major breakthrough, as there is currently no effective medical treatment.
Traumatic brain injury (TBI) is a real concern in Cleveland medical malpractice circles when someone has been in an accident. Whether that injury has been the result of a car crash, a slip and fall accident or other blunt force trauma to the skull (such as blasts from explosives), the consequences are life altering, if not deadly when not treated in a timely manner. Cleveland medical malpractice lawyers see instances like this quite frequently.
There are roughly 1.4 million cases of traumatic brain injury (TBI) in the U.S. every year. Approximately 300,000 of those cases are classified as severe. The fact of the matter is that TBI is the number one cause of disability for those under age 35. This injury results in close to 99,000 cases a year of permanent disability. Fifty percent of those who survive a TBI sustain major impairment. These statistics alone speak loudly enough about the severity of this injury to prompt victims to hire a highly skilled Cleveland malpractice lawyer.
Lest we forget, there are hundreds of cases of military blast injury sustained by our Armed Forces personnel overseas, as a result of roadside bombs. There were approximately 360,000 military blast injuries 2002-2008. Those numbers have not decreased over the last two years. While we may be waging a war against terrorists, the real terror is stalking military personnel in the form of blast injuries. The incidence of deaths due to TBI from bomb blasts is also very high.
In most instances traumatic brain injury is “managed” in order to reduce the pressure on the brain from swelling and to ensure it is receiving enough oxygen. Any breakthrough in the medical field that offers promise for those who have sustained a traumatic brain injury is welcome news. Indeed, most Cleveland medical malpractice attorneys feel new therapy like this may assist their clients in recovery. While the proposed therapy and drug are pending trials in Israel and Switzerland, Oxycyte’s initial results appear to be promising.
This company focuses on pharmaceuticals and medical devices in the field of oxygen therapeutics and continuous substrate monitoring. Their latest offering to the medical community is Oxycyte, a perfluorocarbon therapeutic oxygen carrier and liquid ventilation product and an implantable glucose sensor.
Currently there are six treatment sites planned for each country with clinical trials slated to begin in the second quarter of 2009 and tentatively lasting anywhere from 12 to 18 months. There are many test subjects available, as the Israelis have been dealing with TBI and blast victims for quite some time. Their skill will enable them to utilize this promising therapy and provide clinical test results based on the therapy regime of a single infusion of one of 3 incremental doses of Oxycyte given within 12 hours of injury along with 50% oxygen and the usual care in cases like this.
The hope is that Oxycyte will play a crucial role in assisting in cases dealing with traumatic brain injury, wound care, strokes, heart attacks, surgery, etc.
From the point of view of a Cleveland medical malpractice attorney who deals with TBI as the result of someone else’s negligence, this latest medical news may change the outcome for TBI patients, and that could only be good.